drugset / Trial / NCT03078803

Fecal Transplant for Crohn's Disease

NCT03078803

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To determine the efficacy and safety of serial FMT at inducing and maintaining clinical and endoscopic response in patients with mild to moderate Crohn's disease

Timeline

Start
2017-03-28
Primary completion
2021-06-21
Completion
2022-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplant Other / unclassified Other

Indications